Itb-med Llc

This study tested a new approach to help kidney transplant recipients safely stop taking lifelong anti-rejection medications. It combined a special drug (siplizumab) with an infusion of cells from the kidney donor and mild chemotherapy. The goal was to find the best treatment pla…

This study tested a new drug called TCD601 to see if it's safe and how it works compared to standard treatment in people who just received a kidney transplant. The goal was to help prevent the body's immune system from rejecting the new kidney. The trial was stopped early and inv…